2Dora G W. MicroRNAs in cardiac disease [ J ]. Transl Res, 2011, 157(4) : 226-235.
3Li Q, Song X W, Zou J, et al. Attenuation of microRNA-1 derepresses the eytoskeleton regulatory protein twinfdin-1 to provoke cardiac hypertrophy[J]. J Ce//Sci, 2010, 123(Pt 14) : 2444-2452.
4Fu J J, Gao H, Pi R B, et al. An optimized protocol for culture of cardiomyocyte from neonatal rat[J]. Cytotechnol, 2005, 49(2-3) : 109-116.
5CaiB, PanZ, Lu Y, etal. The roles ofmicroRNAs in heart diseases: a novel important regulator[J]. Curr Med Chem, 2010, 17(5): 407-411.
6Small E M, Olson E N. Pervasive roles of microRNAs in car- diovascular biology [ J ]. Nature, 2011, 469 (7330) : 336- 342.
7Cingolani E, Ramirez Correa G A, Kizana E, et al. Gene therapy to inhibit the calcium channel beta subunit: physio- logical consequences and pathophysiological effects in models of cardiac hypertrophy[J]. Circ Res, 2007, 101(2): 166- 175.
8lkeda S, He A, Kong S W, et d. MicroRNA-I negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes[J]. Mol Cell Biol, 2009, 29(8): 2193- 2204.
9Leach R N, Brette F, Orchard C H. Antisense oligonu- cleotide against the Ca channel beta subunit decreases L-type Ca current in rat ventricular myocytes[ J]. Biochem Biophys Res Convm, 2007, 352(3): 794-798.
10Ambros V. The functions of animal microRNAs[J]. Na- ture, 2004,431 (7006) : 350-355.
